A new study finds semaglutide is linked to an increased risk of vision loss associated with a rare eye condition, but cases remain rare. Here's what experts want you to know.
The Danish Medicines Agency requested the EMA's Pharmacovigilance Risk Assessment Committee review reports on the ...
Researchers have established that the application of once-weekly semaglutide in patients with type 2 diabetes (T2D) increases ...
Health officials in Europe are reportedly investigating Ozempic and the trendy drug’s possible link to an eye-rotting ...
New research suggests popular weight loss medications containing semaglutide may increase risk of rare vision condition, but ...
Electrical stimulation therapy is being explored as a potential treatment to enhance neuroplasticity and improve visual ...
Two large studies from the University of Southern Denmark (SDU) reveal that the diabetes drug Ozempic may double the risk of ...
Learn how two studies from Denmark expand upon earlier U.S. work that first linked the medication with the eye disease.
Because of its complex pathophysiological mechanisms, current treatments for ischemia-reperfusion injury are limited in effectiveness and scope, highlighting the urgent need for new therapies. The ...
Ozempic and Wegovy, used for diabetes and weight loss, show a link to NAION, a rare eye disorder causing blindness. A study ...
How to Choose the Best Hair Loss Treatment for You Finding the right hair loss treatment depends on the type and severity of your hair loss. With so many options available, it’s important to ...
But now it’s well established that the symptoms can persist into adulthood — and a large new study has assessed which treatments may be most effective at alleviating them. Stimulant ...